NYSE:INFU InfuSystem (INFU) Stock Price, News & Analysis $8.97 +0.04 (+0.45%) (As of 05:20 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About InfuSystem Stock (NYSE:INFU) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get InfuSystem alerts:Sign Up Key Stats Today's Range$8.87▼$9.1650-Day Range$5.84▼$9.5152-Week Range$5.74▼$10.99Volume93,886 shsAverage Volume59,495 shsMarket Capitalization$190.70 millionP/E Ratio149.52Dividend YieldN/APrice Target$13.00Consensus RatingStrong Buy Company OverviewInfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.Read More… I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. InfuSystem Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks47th Percentile Overall ScoreINFU MarketRank™: InfuSystem scored higher than 47% of companies evaluated by MarketBeat, and ranked 662nd out of 975 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingStrong Buy Amount of Analyst CoverageInfuSystem has only been the subject of 1 research reports in the past 90 days.Read more about InfuSystem's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth106.67% Earnings GrowthEarnings for InfuSystem are expected to grow by 106.67% in the coming year, from $0.15 to $0.31 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InfuSystem is 149.52, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 136.02.Price to Earnings Ratio vs. SectorThe P/E ratio of InfuSystem is 149.52, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 131.84.Price to Book Value per Share RatioInfuSystem has a P/B Ratio of 3.44. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for INFU. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInfuSystem does not currently pay a dividend.Dividend GrowthInfuSystem does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for INFU. News and Social Media1.7 / 5News Sentiment0.02 News SentimentInfuSystem has a news sentiment score of 0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 11 news articles for InfuSystem this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for INFU on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added InfuSystem to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Company Ownership4.2 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, InfuSystem insiders have bought more of their company's stock than they have sold. Specifically, they have bought $23,560.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders10.20% of the stock of InfuSystem is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions71.13% of the stock of InfuSystem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about InfuSystem's insider trading history. Receive INFU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter. Email Address INFU Stock News HeadlinesB. Riley Issues Pessimistic Estimate for InfuSystem EarningsNovember 12 at 2:23 AM | americanbankingnews.comInfuSystem Holdings, Inc. (AMEX:INFU) Q3 2024 Earnings Call TranscriptNovember 11 at 8:58 AM | msn.comWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.November 14, 2024 | Porter & Company (Ad)InfuSystem Holdings, Inc. (INFU) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comQ3 2024 InfuSystem Holdings Inc Earnings CallNovember 8, 2024 | finance.yahoo.comCraig-Hallum Sticks to Their Buy Rating for Lifecore Biomedical (LFCR)November 7, 2024 | markets.businessinsider.comInfuSystem Reports Third Quarter 2024 Financial ResultsNovember 7, 2024 | businesswire.comInotiv (NOTV) Receives a Buy from Craig-HallumNovember 6, 2024 | markets.businessinsider.comSee More Headlines INFU Stock Analysis - Frequently Asked Questions How have INFU shares performed this year? InfuSystem's stock was trading at $7.14 at the start of the year. Since then, INFU shares have increased by 25.6% and is now trading at $8.97. View the best growth stocks for 2024 here. How were InfuSystem's earnings last quarter? InfuSystem Holdings, Inc. (NYSE:INFU) posted its quarterly earnings results on Thursday, August, 8th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by $0.01. The company had revenue of $33.70 million for the quarter. InfuSystem had a trailing twelve-month return on equity of 2.78% and a net margin of 1.12%. Who are InfuSystem's major shareholders? Top institutional investors of InfuSystem include Greenwood Capital Associates LLC (0.56%), GSA Capital Partners LLP (0.31%), Oppenheimer Asset Management Inc. (0.16%) and Connor Clark & Lunn Investment Management Ltd. (0.06%). Insiders that own company stock include Richard Dilorio, Christopher R Sansone, Carrie Lachance, Barry G Steele, Paul Andrew Gendron, R Rimmy Malhotra, Thomas Mark Ruiz, Addam Chupa, Ralph F Boyd Jr, Kevin Whitman, Kenneth D Eichenbaum, Gregg Owen Lehman and Jeannine Sheehan. View institutional ownership trends. How do I buy shares of InfuSystem? Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of InfuSystem own? Based on aggregate information from My MarketBeat watchlists, some other companies that InfuSystem investors own include Advanced Micro Devices (AMD), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), Home Depot (HD), JPMorgan Chase & Co. (JPM) and Netflix (NFLX). Company Calendar Last Earnings8/08/2024Today11/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNYSE:INFU Previous SymbolNYSE:INFU CUSIPN/A CIK1337013 Webwww.infusystem.com Phone(248) 291-1210Fax800-455-4338Employees499Year FoundedN/APrice Target and Rating Average Stock Price Target$13.00 High Stock Price Target$13.00 Low Stock Price Target$13.00 Potential Upside/Downside+43.2%Consensus RatingStrong Buy Rating Score (0-4)4.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$0.06 Trailing P/E Ratio151.36 Forward P/E Ratio60.53 P/E GrowthN/ANet Income$870,000.00 Net Margins1.12% Pretax Margin2.65% Return on Equity2.78% Return on Assets1.41% Debt Debt-to-Equity Ratio0.50 Current Ratio1.98 Quick Ratio1.64 Sales & Book Value Annual Sales$125.79 million Price / Sales1.53 Cash Flow$0.61 per share Price / Cash Flow14.92 Book Value$2.61 per share Price / Book3.48Miscellaneous Outstanding Shares21,260,000Free Float19,095,000Market Cap$193.04 million OptionableOptionable Beta1.45 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report This page (NYSE:INFU) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThis small cap’s electric marine powertrain broke the world speed recordThe future of marine propulsion has arrived-powered by a $2 billion powerhouse. In collaboration with McLar...The Tomorrow Investor | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredThe next assassination attempt won’t be on TrumpPresident Trump is soon to be back in the White House. Unity has been restored to the U.S. But if you wa...Porter & Company | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InfuSystem Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InfuSystem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.